Inside informationEnglish
Press Release: Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 23/12/2025, 15:06
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 116464_20251223